02
Services / Products
Clinical Trials
-
Interventional and non interventional studies
RIPH1, RIPH2, RIPH3
Early Access (EAP), Compassionate Access (AAC)
and Compassionate Use Program
Early Access Program reform of July 1st -
Drugs
All clinical phases
Many indications including oncology, neurology…
CAR-T cell, Innovative Medicines… -
Medical devices
Study management to demonstrate safety
and performance of theMD for EC marking
ISO 14155
Post-marketing study MDR 2017/745/EU -
Dermo-cosmetics
Class I to III
Post-marketing and non-interventional study
Collaboration with sites of excellence -
Nutrition
Health risk assessment and level of tolerance or allergy
Post-registration study for foods for medical purposes
Health claims
